Idiopathic pulmonary fibrosis: recent advances on pharmacological therapy
Idiopathic pulmonary fibrosis (IPF) is the most common and lethal of the idiopathic interstitial pneumonias with an estimated 5-year survival of approximately 20%. In the last two decades our understanding of disease pathogenesis has substantially evolved and novel compounds have been developed cons...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2015-05-03.
|
| Subjects: | |
| Online Access: | Get fulltext |